Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 145
Number of items: 145
  • van Vliet, E. A., Zibell, G., Pekcec, A., Schlichtiger, J., Edelbroek, P. M., Holtman, L., Aronica, E., Gorter, J. A., & Potschka, H. (2010). COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats. Neuropharmacology, 58(2), 404-412. https://doi.org/10.1016/j.neuropharm.2009.09.012
  • Aronica, E., Fluiter, K., Iyer, A., Zurolo, E., Vreijling, J., van Vliet, E. A., Baayen, J. C., & Gorter, J. A. (2010). Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. European Journal of Neuroscience, 31(6), 1100-1107. https://doi.org/10.1111/j.1460-9568.2010.07122.x
  • Holtman, L., van Vliet, E. A., Edelbroek, P. M., Aronica, E., & Gorter, J. A. (2010). Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy. Epilepsy Research, 91(1), 49-56. https://doi.org/10.1016/j.eplepsyres.2010.06.011
  • Gorter, J. A., Zurolo, E., Iyer, A., Fluiter, K., van Vliet, E. A., Baayen, J. C., & Aronica, E. (2010). Induction of sodium channel Nax (SCN7A) expression in rat and human hippocampus in temporal lobe epilepsy. Epilepsia, 51(9), 1791-1800. https://doi.org/10.1111/j.1528-1167.2010.02678.x
  • van Vliet, E. A., Edelbroek, P. M., & Gorter, J. A. (2010). Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats. Epilepsia, 51(3), 362-370. https://doi.org/10.1111/j.1528-1167.2009.02261.x
  • van Vliet, E. (2009). Farmacoresistente epilepsie: mogelijke oorzaken. Epilepsie, 3(7), 27-29. http://www.epilepsieliga.nl/upload/_122_pageitems_276_ligablad%20september%202009.pdf
  • Pekcec, A., Unkrüer, B., Schlichtiger, J., Soerensen, J., Hartz, A. M. S., Bauer, B., van Vliet, E. A., Gorter, J. A., & Potschka, H. (2009). Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation. The Journal of Pharmacology and experimental Therapeutics, 330(3), 939-947. https://doi.org/10.1124/jpet.109.152520
  • Holtman, L., van Vliet, E. A., van Schaik, R., Queiroz, C. M., Aronica, E., & Gorter, J. A. (2009). Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy. Epilepsy Research, 84(1), 56-66. https://doi.org/10.1016/j.eplepsyres.2008.12.006
  • van Vliet, E. A., Aronica, E. M. A., Redeker, S., Boer, K., & Gorter, J. A. (2009). Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy. Epilepsia, 50(3), 422-433. https://doi.org/10.1111/j.1528-1167.2008.01727.x
  • van Vliet, E. A., van Schaik, R., Edelbroek, P. M., Lopes da Silva, F. H., Wadman, W. J., & Gorter, J. A. (2008). Development of tolerance to levetiracetam in rats with chronic epilepsy. Epilepsia, 49(7), 1151-1159. https://doi.org/10.1111/j.1528-1167.2007.01516.x
Page 11 of 15